Bombesin
- Generic Name
- Bombesin
- Drug Type
- Small Molecule
- Chemical Formula
- C71H110N24O18S
- CAS Number
- 31362-50-2
- Unique Ingredient Identifier
- PX9AZU7QPK
- Background
Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers).
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers
- First Posted Date
- 2010-09-20
- Last Posted Date
- 2013-01-21
- Lead Sponsor
- Life Molecular Imaging SA
- Target Recruit Count
- 19
- Registration Number
- NCT01205321
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath